News

The insider still retains significant holdings, valued at $8.5 million, despite the sale.

What would have happened if you invested in the S&P 500 right before two of the worst market crashes in recent history?

Non-discretionary sale tied to restricted stock unit vesting for tax withholding. Chaudhry retains $5.15 billion in beneficial ownership through family trusts.

XPeng’s central valuation estimate has been reset, with Fair Value moving from US$22.36 to US$19.06. This change reframes how investors may think about potential upside in the stock. The wide spread in updated Street targets, now roughly between US$12 and US$24, reflects differing views on XPeng’s ability to balance growth plans, robotics optionality and the execution questions raised in recent research. As you read on, you will see how to track these shifting assumptions and follow the...

Aptiv’s fair value estimate has moved from US$78.21 to US$66.61, pointing to a reduced assessed upside compared with earlier models. This shift lines up with a split analyst narrative, where optimism around the post EDS separation mix and software exposure is balanced against caution on auto sector headwinds, execution questions and softer guidance. Read on to see how these views are shaping the evolving story around Aptiv and what to watch as new data comes through. Stay updated as the Fair...

When the Nasdaq craters, the gap between 2x and 3x leverage stops being an academic footnote and starts costing real money. What investors in TQQQ discover the hard way, QLD holders already knew.

Health Catalyst is back in focus after analysts revised fair value from about US$2.10 to roughly US$1.83 per share, which points to a more cautious stance on the stock. Recent research has shifted from earlier optimism with price targets in the US$2 to US$3 range to current levels closer to US$1.80, as analysts weigh execution risks around churn, divestitures and the durability of growth in its health technology offerings. In this article, you will see how these changing targets fit into the...

Wood made a major Magnificent Seven purchase in the ARK Innovation ETF.

When investors’ willingness to take risks rapidly rises, look out below.

BioMarin Pharmaceutical recently reported positive Phase 3 CANOPY-HCH-3 results for VOXZOGO in children with hypochondroplasia and submitted a supplemental FDA application to expand the drug’s use, while also adding Bristol Myers Squibb research leader Robert Plenge, M.D., Ph.D., to its Board and Science and Technology Committee. The combination of strong late-stage VOXZOGO data in an indication with no approved treatments and the addition of a seasoned R&D executive to the board underscores...

Moderna (MRNA) has been back in the spotlight after its appearance at the Morgan Stanley Global Healthcare Conference, where management highlighted progress across its vaccine portfolio and ongoing Phase 3 work on personalized cancer candidate intismeran. Recent trading has been volatile for Moderna, with a 1-day share price return that declined 2.55% after the latest close at US$154.04. However, a 7-day share price return of 6.99% and a 90-day gain of 140.84% indicate upward momentum that...

Though McCormick has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Verizon Communications (NYSE:VZ) and Siyata announced a new 5G mission-critical Push-to-Talk handset for frontline workers. The device is aimed at users in public safety, security, education, and construction who need simple and reliable field communications. The handset is built for challenging environments where traditional smartphones may not offer the same level of durability or usability. The Verizon and Siyata Push-to-Talk launch is important, but the full story is in how this shapes...

Investing.com -- NASA and Boeing are discussing using the Starliner spacecraft for 10 or more new missions to low-Earth orbit, despite technical failures during its troubled 2024 crewed test flight, the Wall Street Journal reported exclusively.

An interest rate hike amid soaring energy costs and rising inflation concerns has weighed on the Dow.

A number of stocks fell in the afternoon session after markets remained volatile during the last trading session of the week, reflecting growing uncertainty, with the broad market retreat erasing the sector's gains from the previous day.

IBM stock fell 25% after a weak Q2. Here's why Red Hat, hybrid cloud, and a 31-year dividend streak keep its comeback case alive.

Zoetis (ZTS) closed at $71.4 in the latest trading session, marking a -2.22% move from the prior day.

The latest trading day saw PagSeguro Digital Ltd. (PAGS) settling at $9.26, representing a -3.14% change from its previous close.

In the latest trading session, Dropbox (DBX) closed at $36.48, marking a -3% move from the previous day.

In the latest trading session, Gladstone Commercial (GOOD) closed at $12.61, marking a -1.1% move from the previous day.

The disposal was executed under a pre-established Rule 10b5-1 trading plan adopted in August 2025, reducing the insider's direct stake to 56,858 shares.

In the latest trading session, AppFolio (APPF) closed at $214.85, marking a -2.22% move from the previous day.

In the most recent trading session, Itron (ITRI) closed at $90.24, indicating a -1.25% shift from the previous trading day.

Sony (SONY) concluded the recent trading session at $23.46, signifying a -1.55% move from its prior day's close.

A seven-figure VOO balance sounds like a retirement paycheck until you do the actual math on what it deposits each month, then realize covering the rest means a tax bill your fund prospectus quietly ignores.

Leidos (LDOS) concluded the recent trading session at $127.69, signifying a -2.5% move from its prior day's close.

In the latest trading session, Plug Power (PLUG) closed at $2.08, marking a -1.89% move from the previous day.

In the most recent trading session, ServiceNow (NOW) closed at $135.47, indicating a -2.17% shift from the previous trading day.

Cathie Wood's ARK Invest funds made a broad move out of crypto-linked assets during the week, led by the sale of more than 1.5 million shares of the ARK 21Shares Bitcoin ETF.